Rishi Rakhit

Rishi Rakhit, PhD, serves at Mitokinin’s Director of Translational Medicine. In that capacity, Dr. Rakhit oversees the Company’s biomarker development and in vivo translational efforts.

Dr. Rakhit is the inventor of two clinical-stage antibody therapeutics and several more in pre-clinical development for neurodegenerative disease. Prior to Mitokinin, Dr. Rakhit held team and project leadership positions at Denali Therapeutics and Achaogen Inc. He has published first author papers in Nature Medicine, eLife, and others, as well as presented as an invited speaker at major international meetings.

Dr. Rakhit received his PhD in biochemistry from University of Toronto (Chakrabartty lab), and completed his post-doctoral training in protein engineering and proteomics in the lab of Tom Wandless at Stanford University.